October 18, 2022 Issue of JAMA

October 18, 2022, Vol 328, No. 15, Pages 1483-1570

This Week in JAMA

Audio Highlights

Abstract Full Text

free access online only has audio

JAMA. 2022;328(15):e2117174. doi:10.1001/jama.2021.17174

Podcast: Spinal Cord Stimulation for Chronic Back Pain, Prescription Drug Spending in Medicare, USPSTF Recommendation on Screening for Depression and Suicide Risk in Children and Adolescents, and more

Original Investigation

Effect of Spinal Cord Burst Stimulation vs Placebo Stimulation on Disability in Patients With Chronic Radicular Pain After Lumbar Spine Surgery: A Randomized Clinical Trial

Sozaburo Hara, MD; Hege Andresen, RN, MSc; Ole Solheim, MD, PhD; et al.

Abstract Full Text

free access

JAMA. 2022;328(15):1506-1514. doi:10.1001/jama.2022.18231

This placebo-controlled, crossover randomized clinical trial compares the effects of spinal cord burst stimulation vs placebo stimulation in patients with chronic radiculopathy after surgery for degenerative lumbar spine disorders.

Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019

Stacie B. Dusetzina, PhD; Haiden A. Huskamp, PhD; Xuanzi Qin, PhD; et al.

Abstract Full Text

free access

JAMA. 2022;328(15):1515-1522. doi:10.1001/jama.2022.17825

This cross-sectional analysis estimates the proportion of health care spending contributed by prescription drugs as well as examines spending for retail and clinician-administered prescriptions.

Editorial
Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act
Walid F. Gellad, MD, MPH; Inmaculada Hernandez, PharmD, PhD

JAMA

Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers

The HEROES-RECOVER Network

Abstract Full Text

free access has active quiz

JAMA. 2022;328(15):1523-1533. doi:10.1001/jama.2022.18550

This study uses a prospective cohort of essential and frontline workers in 6 US states with SARS-CoV-2 infection to examine associations between 2 or 3 doses of mRNA COVID-19 vaccine and attenuation of symptoms and viral RNA load across SARS-CoV-2 viral lineages.

Research Letter

Trends in Urinary Catheter Use by Indication in US Emergency Departments, 2002-2019

Katherine Dickerson Mayes, MD, PhD; Jeremiah D. Schuur, MD, MHS; Shih-Chuan Chou, MD, MPH, SM

Abstract Full Text

free access

JAMA. 2022;328(15):1557-1559. doi:10.1001/jama.2022.14378

This retrospective study examines trends in urinary catheter use in US emergency departments between 2002 and 2019.

Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose

Jessica P. Ridgway, MD; Samuel Tideman, MS; Thomas French, MS; et al.

Abstract Full Text

free access has active quiz

JAMA. 2022;328(15):1559-1561. doi:10.1001/jama.2022.17811

This study assesses the association between COVID-19 mRNA booster immunization compared with vaccination with the primary mRNA vaccination series alone and odds of hospitalization for COVID-19.

US Preventive Services Task Force

Recommendation Statement

Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force

Abstract Full Text

free access has active quiz has audio

JAMA. 2022;328(15):1534-1542. doi:10.1001/jama.2022.16946

This 2022 Recommendation Statement from the US Preventive Services Task Force recommends screening for major depressive disorder (MDD) in adolescents aged 12 to 18 years (B recommendation) and concludes that current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children 11 years or younger (I statement) and of screening for suicide risk in children and adolescents (I statement).

Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Editorial
Screening for Adolescent Depression and Suicide Risk
Oscar G. Bukstein, MD, MPH

JAMA

Evidence Report

Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Meera Viswanathan, PhD; Ina F. Wallace, PhD; Jennifer Cook Middleton, PhD; et al.

Abstract Full Text

free access has active quiz has audio

JAMA. 2022;328(15):1543-1556. doi:10.1001/jama.2022.16310

This systematic review to support the 2022 US Preventive Services Task Force Recommendation Statement on screening for depression and suicide risk in children and adolescents summarizes published evidence on the benefits and harms of screening for and treatment of depression and suicide risk in children and adolescents 18 years or younger.

Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Editorial
Screening for Adolescent Depression and Suicide Risk
Oscar G. Bukstein, MD, MPH

JAMA

Viewpoint

Moving to More Evidence-Based Primary Care Encounters: A Farewell to the Review of Systems

Michael J. Barry, MD; Chien-Wen Tseng, MD, MPH

Abstract Full Text

JAMA. 2022;328(15):1495-1496. doi:10.1001/jama.2022.18346

This Viewpoint discusses ways in which free time during patient visits, resulting from removal of tradition- and reimbursement-driven care in favor of more evidence-based care, could be used to achieve better health outcomes based on recommendations from the US Preventive Services Task Force evidence-based preventive care.

Improving Prior Authorization in Medicare Advantage

Kelly E. Anderson, PhD, MPP; Michael Darden, PhD; Amit Jain, MD, MBA

Abstract Full Text

JAMA. 2022;328(15):1497-1498. doi:10.1001/jama.2022.17732

This Viewpoint discusses the potential benefits and harms of prior authorization in Medicare Advantage and the health policy implications and opportunities for improvement.

The Supreme Court Decision on Federal Prescribing Rules for Controlled Substances

Matt Lamkin, JD, MA

Abstract Full Text

JAMA. 2022;328(15):1499-1500. doi:10.1001/jama.2022.18308

This Viewpoint explains how a recent Supreme Court decision clarifies rules for prescribing controlled substances so that patients are not denied appropriate care and physicians are not unjustly prosecuted.

A Piece of My Mind

The Color Yellow

Sarah B. Calvert, MD

Abstract Full Text

JAMA. 2022;328(15):1501. doi:10.1001/jama.2022.16235

In this narrative medicine essay, a third-year pediatric resident鈥檚 descriptions of the yellow colors in medicine demonstrate her sense of comfort in her profession in contrast with the uncertainty she feels as she enters her new life of motherhood.

Editorial

Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act

Walid F. Gellad, MD, MPH; Inmaculada Hernandez, PharmD, PhD

Abstract Full Text

JAMA. 2022;328(15):1502-1503. doi:10.1001/jama.2022.18624

Screening for Adolescent Depression and Suicide Risk

Oscar G. Bukstein, MD, MPH

Abstract Full Text

JAMA. 2022;328(15):1504-1505. doi:10.1001/jama.2022.15223

Medical News & Perspectives

The Dreaded 鈥淭windemic鈥� of Influenza and COVID-19 Has Not Yet Materialized鈥擬ight This Be the Year?

Rita Rubin, MA

Abstract Full Text

free access has audio

JAMA. 2022;328(15):1488-1489. doi:10.1001/jama.2022.15062

This Medical News feature discusses the challenges of predicting how severe flu season might be.

Podcast: September 2022 Medical News Summary

News From the Food and Drug Administration

Another Recall Involving Philips Positive Airway Pressure Machines

Rita Rubin, MA

Abstract Full Text

JAMA. 2022;328(15):1492. doi:10.1001/jama.2022.15478

New Breast Implant Safety Concerns

Rita Rubin, MA

Abstract Full Text

JAMA. 2022;328(15):1492. doi:10.1001/jama.2022.15477

Partnership Focuses on Neurodegenerative Diseases

Rita Rubin, MA

Abstract Full Text

JAMA. 2022;328(15):1492-1493. doi:10.1001/jama.2022.15479

Global Health

Rotavirus Leads Global Diarrhea Hospitalizations Among Young Children

Deanna Bellandi, MPH

Abstract Full Text

JAMA. 2022;328(15):1490. doi:10.1001/jama.2022.15474

Estimate: 10.5 Million Children Lost a Parent, Caregiver to COVID-19

Deanna Bellandi, MPH

Abstract Full Text

free access

JAMA. 2022;328(15):1490. doi:10.1001/jama.2022.15475

An Association Between Heavy Rainfall and HIV in Sub-Saharan Africa

Deanna Bellandi, MPH

Abstract Full Text

JAMA. 2022;328(15):1490. doi:10.1001/jama.2022.15476

Global Health Care Facilities Lack Basic Hygiene Services

Deanna Bellandi, MPH

Abstract Full Text

JAMA. 2022;328(15):1490-1491. doi:10.1001/jama.2022.18765

Poetry and Medicine

Christmas at the New ICU

William Palmer

Abstract Full Text

JAMA. 2022;328(15):1565. doi:10.1001/jama.2022.10081

JAMA Revisited

Interepidemic Influenza

Abstract Full Text

JAMA. 2022;328(15):1566. doi:10.1001/jama.2021.17175

JAMA Patient Page

Screening for Depression and Suicide Risk in Children and Adolescents

Jill Jin, MD, MPH

Abstract Full Text

free access

JAMA. 2022;328(15):1570. doi:10.1001/jama.2022.18187

This JAMA Patient Page summarizes the US Preventive Services Task Force鈥檚 recommendations on screening for depression and suicide risk in children and adolescents.